At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Jun 18, 2026 at 20:08 ET
Two top C-suite executives at Vaxcyte (CEO and CFO) sold a combined ~$542K in open-market sales on June 18, 2026, following the exercise of stock options. The sales are small relative to the $7.3B market cap (~0.007%), making them routine and likely tax-related or liquidity-driven. No material bearish signal.
- CEO Grant Pickering sold 225 shares for ~$11.8K on June 18
- CFO Andrew Guggenhime sold 10,000 shares for $530K on June 18
- Both sales followed option exercises at nominal prices ($0 and $1.79/$5.35)
- Total open-market sales: ~$542K, or 0.007% of $7.3B market cap
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access